Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucie Loyal

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Nature Communications|November 25, 2023
Associations of myeloid cells with cellular and humoral responses following vaccinations in patients with neuroimmunological diseasesMeng Wang, Adeline Dehlinger, Camila Fernández Zapata, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 5, 2022
Cutting Edge: Serum but Not Mucosal Antibody Responses Are Associated with Pre-Existing SARS-CoV-2 Spike Cross-Reactive CD4<sup>+</sup> T Cells following BNT162b2 Vaccination in the ElderlyLil Meyer-Arndt, Tatjana Schwarz, Lucie Loyal, et al.
Cell Reports|February 17, 2025
Hybrid immunity-based induction of durable pan-endemic-coronavirus immunity in the elderlyLucie Loyal, Julian Braun, Ulf Reimer, et al.
Frontiers in Immunology|February 17, 2023
Primary ChAdOx1 vaccination does not reactivate pre-existing, cross-reactive immunityLarissa Henze, Julian Braun, Lil Meyer-Arndt, et al.
European Journal of Immunology|July 29, 2025
Aging and Viral Evolution Impair Immunity Against Dominant Pan-Coronavirus-Reactive T Cell EpitopeLucie Loyal, Karsten Jürchott, Ulf Reimer, et al.
Science Advances|May 21, 2025
CD8<sup>+</sup> T cell-derived CD40L mediates noncanonical cytotoxicity in CD40-expressing cancer cellsPhillip Schiele, Alberto Sada Japp, Regina Stark, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 14, 2022
SARS-CoV-2 mRNA vaccinations fail to elicit humoral and cellular immune responses in patients with multiple sclerosis receiving fingolimodLil Meyer-Arndt, Julian Braun, Florent Fauchere, et al.
Nature|July 30, 2020
SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19Julian Braun, Lucie Loyal, Marco Frentsch, et al.
Science (New York, N.Y.)|September 1, 2021
Cross-reactive CD4<sup>+</sup> T cells enhance SARS-CoV-2 immune responses upon infection and vaccinationLucie Loyal, Julian Braun, Larissa Henze, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Nature Communications|November 25, 2023
Associations of myeloid cells with cellular and humoral responses following vaccinations in patients with neuroimmunological diseasesMeng Wang, Adeline Dehlinger, Camila Fernández Zapata, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 5, 2022
Cutting Edge: Serum but Not Mucosal Antibody Responses Are Associated with Pre-Existing SARS-CoV-2 Spike Cross-Reactive CD4<sup>+</sup> T Cells following BNT162b2 Vaccination in the ElderlyLil Meyer-Arndt, Tatjana Schwarz, Lucie Loyal, et al.
Cell Reports|February 17, 2025
Hybrid immunity-based induction of durable pan-endemic-coronavirus immunity in the elderlyLucie Loyal, Julian Braun, Ulf Reimer, et al.
Frontiers in Immunology|February 17, 2023
Primary ChAdOx1 vaccination does not reactivate pre-existing, cross-reactive immunityLarissa Henze, Julian Braun, Lil Meyer-Arndt, et al.
European Journal of Immunology|July 29, 2025
Aging and Viral Evolution Impair Immunity Against Dominant Pan-Coronavirus-Reactive T Cell EpitopeLucie Loyal, Karsten Jürchott, Ulf Reimer, et al.
Science Advances|May 21, 2025
CD8<sup>+</sup> T cell-derived CD40L mediates noncanonical cytotoxicity in CD40-expressing cancer cellsPhillip Schiele, Alberto Sada Japp, Regina Stark, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 14, 2022
SARS-CoV-2 mRNA vaccinations fail to elicit humoral and cellular immune responses in patients with multiple sclerosis receiving fingolimodLil Meyer-Arndt, Julian Braun, Florent Fauchere, et al.
Nature|July 30, 2020
SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19Julian Braun, Lucie Loyal, Marco Frentsch, et al.
Science (New York, N.Y.)|September 1, 2021
Cross-reactive CD4<sup>+</sup> T cells enhance SARS-CoV-2 immune responses upon infection and vaccinationLucie Loyal, Julian Braun, Larissa Henze, et al.
Pageof 2